KYTHERA BIOPHARMACEUTICALS INC 4
4 · KYTHERA BIOPHARMACEUTICALS INC · Filed May 4, 2015
Insider Transaction Report
Form 4
Samuels Camille D
Director10% Owner
Transactions
- Sale
Common Stock
2015-05-01$43.66/sh−105$4,584→ 14,830 total - Sale
Common Stock
2015-05-01$45.48/sh−145$6,595→ 14,685 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to the Reporting Person's 10b5-1 plan which expires December 31, 2015.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $43.52 to $43.67, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.